Taiwanese Pharmaceuticals & Biotech Mid-Large Cap Stocks

Lotus Pharmaceutical

Market Cap: NT$59.5b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$73.8b

Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.

Caliway Biopharmaceuticals

Market Cap: NT$121.1b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Polaris Group

Market Cap: NT$33.5b

Offers biotechnology, drug testing, and contract development and manufacturing services.

PharmaEssentia

Market Cap: NT$167.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.